NCT03050073 is a clinical trial in Choroidal Thickness, sponsored by Fondation Hôpital Saint-Joseph.

Who is sponsoring NCT03050073?

NCT03050073 is sponsored by Fondation Hôpital Saint-Joseph.

What condition does NCT03050073 study?

NCT03050073 studies Choroidal Thickness.

Is NCT03050073 still recruiting?

NCT03050073 is currently completed. Last updated 10 August 2018.

Last reviewed 2018-08-10 · How we verify

NCT03050073

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Choroidal Thickness Association With Primary Angle Closure

Completed Last updated 10 August 2018

What this trial tests

trial in Choroidal Thickness in 42 participants. Completed in 31 December 2016.

Timeline

18 April 2016

Primary endpoint
30 June 2016

31 December 2016

Quick facts

Lead sponsor	Fondation Hôpital Saint-Joseph
Status	Completed
Study type	OBSERVATIONAL
Enrollment	42
Start date	18 April 2016
Primary completion	30 June 2016
Estimated completion	31 December 2016
Sites	1 location across France

Conditions studied

Choroidal Thickness — all drugs for Choroidal Thickness →

Sponsor

Fondation Hôpital Saint-Joseph — full company profile →

Who can join

18 and older, any sex, with Choroidal Thickness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A chinese study shows that chinese population eyes with a primary angle closure have a greater choroidal thickness than normal eyes.The increase of choroidal thickness would be associated to this primary angle closure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Choroidal Thickness

Currently open trials in the same condition.

NCT06717048 — Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression · NA · recruiting

Other Fondation Hôpital Saint-Joseph trials

Trials by the same sponsor.

NCT07512960 — Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization · Phase 3 · not yet recruiting
NCT07512908 — Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Di · NA · not yet recruiting
NCT07512830 — Evaluation of the Benefits of Hypnosis During Transoesophageal Echocardiography · NA · recruiting
NCT07348081 — Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers · NA · recruiting
NCT07086612 — Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03050073 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondation Hôpital Saint-Joseph
Last refreshed: 10 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03050073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing